Disclaimer Statement

Updated:

Author: Engineer USC

ALPMY Stock Forecast & Astellas Pharma Chart Analysis

This article provides a detailed analysis of ALPMY-Astellas Pharma Inc. stock including a forecast for ALPMY shares. It features Astellas Pharma Inc. technical analysis, support and resistance levels, financial report evaluations, buy and sell signals based on simple moving averages and MACD, and artificial intelligence-assisted target price predictions

Stocks can be purchased through banks, brokerage firms, investment funds, and individual retirement systems.

ALPMY Historical Data Review

ALPMY Current Price Performance Analysis

The Astellas Pharma - ALPMY stock traded on the American stock market, on 06-05-2024, closed at 10.23$ with a %1.69 increased compared to the previous day.

In the last month, the price of ALPMY changed by %1.69 increased in value, from 10.06 dollars on 05-06-2024 to 10.23 dollars, increased.

Last year, the price of ALPMY was 16.5 dollars on 06-06-2023, and changed by %-38.00 decreased in value, to 10.23 dollars decreased within a year.

The price of Astellas Pharma stock is riding high above the 50-day and 100-day moving averages. This means it's on a positive run for now, great news for those who got in early. But let's not take our eyes off the ball; no stock climbs forever.

ALPMY with AI Stock Forecast & Price Target

ALPMY stock forecast Astellas Pharma price target

On the ALPMY chart Astellas Pharma price was recorded as 10.23 Dollars on 06/05/2024.

The artificial intelligence's forecast on ALPMY stock is as follows.

The artificial intelligence's prediction error margin for ALPMY stock is very high.

There are two types of risk factors in the artificial intelligence's targets: timing and target prices.

For example, the target price for one month later may be realized three months later. But there is no guarantee of this.

The average predicted price for Astellas Pharma stock over the next 4 months is: 6.9 Dollars.

The commentary on ALPMY stock Target Price: Highest: 9.782 Dollars is predicted.

The commentary on ALPMY stock Target Price: Lowest: 4.285 Dollars is predicted.

The commentary on ALPMY stock: The target price can generally be said to be on the decline.

The target price for Astellas Pharma stock by the end of 2024 is predicted to be 6.368 Dollars.

The price prediction graph prepared with the help of artificial intelligence, the commentary on ALPMY stock, and the 2024 target price predictions for Astellas Pharma are detailed above.

The technical analysis and charts for the commentary on ALPMY stock are below.

ALPMY Support & Resistance and Trend Analysis

ALPMY review Astellas Pharma Inc. technical analysis trend chart ALPMY priceALPMY stock support and resistance price chart

ALPMY stock you have reviewed the technical analysis support resistance charts regarding.

ALPMY : Targeting Support and Resistance Price Levels

According to the algorithmic analysis results related to the ALPMY review, the Astellas Pharma support and resistance prices are as follows.

Support and resistance levels on the chart are not absolute. They may vary depending on market conditions and macroeconomic indicators.

Astellas Pharma Support and Resistance Prices:

ALPMY Support Level Price ALPMY Resistance Level Price
9.15 10.30
9.42 11.16
10.29 11.32
10.39 11.55
11.15 11.88
11.25 12.55
11.47 12.71
11.71

ALPMY Technical Analysis: SMA, RSI, MACD

ALPMY review Astellas Pharma Inc. SMA chart analysis ALPMY priceALPMY buy or sell review Astellas Pharma Inc. MACD chart analysis ALPMY price

Upon reviewing the ALPMY chart, buy and sell signals have been generated in the Astellas Pharma technical analysis with technical indicators. There are over 100 technical indicators in the market. Each technical indicator can produce different signals.

However, please remember that technical analysis is only a tool and exact results cannot be guaranteed.

On The technical analysis chart and stock comments for ALPMY stock are as follows:
  1. The technical analysis for ALPMY indicates that the 14-period RSI has most recently generated a 'Sell' signal.
  2. The technical analysis for ALPMY indicates that the MACD indicator (with parameters 9, 12, 26) has most recently generated a 'Buy' signal.
  3. The technical analysis for Astellas Pharma issued a 'Buy' signal when the MACD was at -0.322, with the current MACD value being: 0.027

Basic Technical Analysis Tips for Financial Markets

  • Moving averages may not yield reliable results in stagnant, sideways markets.
  • According to MACD technical analysis, the most optimal buying opportunity is a 'Buy' signal given when the MACD is below the 0 level.
  • An RSI crossing below 70 is used as a sell signal, and a crossing above 30 is used as a buy signal.
  • During a strong upward trend, the RSI can rise above 70 and stay there.
  • No indicator is perfect. Having indicators corroborate each other can increase the chances of success.
  • Instead of fully relying on these indicators for your investment decisions, it is recommended to conduct a comprehensive analysis and consult a professional financial advisor.

You have read the comments, technical analyses, target prices, and financial reports for Astellas Pharma stock: Click here to read more predictions on Eversource Energy stock.

Click here for price target predictions and technical analysis charts of other American stocks